. . . . . . . . . . "67269270"^^ . "1117007400"^^ . "GRAd-COV2 \u2014 \u043A\u0430\u043D\u0434\u0438\u0434\u0430\u0442 \u043D\u0430 \u0432\u0430\u043A\u0446\u0438\u043D\u0443 \u043F\u0440\u043E\u0442\u0438 COVID-19, \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0456\u0442\u0430\u043B\u0456\u0439\u0441\u044C\u043A\u0438\u043C\u0438 \u0431\u0456\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0456\u0447\u043D\u043E\u044E \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u00ABReiThera Srl\u00BB \u0442\u0430 \u041D\u0430\u0446\u0456\u043E\u043D\u0430\u043B\u044C\u043D\u0438\u043C \u0456\u043D\u0441\u0442\u0438\u0442\u0443\u0442\u043E\u043C \u0456\u043D\u0444\u0435\u043A\u0446\u0456\u0439\u043D\u0438\u0445 \u0445\u0432\u043E\u0440\u043E\u0431 \u0456\u043C\u0435\u043D\u0456 \u041B\u0430\u0434\u0437\u0430\u0440\u043E \u0421\u043F\u0430\u043B\u043B\u0430\u043D\u0446\u0430\u043D\u0456. \u0412 \u043E\u0441\u043D\u043E\u0432\u0456 \u0446\u0456\u0454\u0457 \u0432\u0430\u043A\u0446\u0438\u043D\u0438 \u043B\u0435\u0436\u0438\u0442\u044C \u043D\u043E\u0432\u0438\u0439 \u0434\u0435\u0444\u0435\u043A\u0442\u043D\u0438\u0439 \u0440\u0435\u043F\u043B\u0456\u043A\u0430\u0446\u0456\u0439\u043D\u0438\u0439\u0443 \u0430\u0434\u0435\u043D\u043E\u0432\u0456\u0440\u0443\u0441 \u0433\u043E\u0440\u0438\u043B\u0438 \u0442\u0430 \u043A\u043E\u0434\u0443\u0454 \u0441\u0442\u0430\u0431\u0456\u043B\u0456\u0437\u043E\u0432\u0430\u043D\u0438\u0439 \u0431\u0456\u043B\u043E\u043A \u0448\u0438\u043F\u043E\u0432\u0438\u0434\u043D\u0438\u0445 \u0432\u0456\u0434\u0440\u043E\u0441\u0442\u043A\u0456\u0432 \u043E\u0431\u043E\u043B\u043E\u043D\u043A\u0438 \u0432\u0456\u0440\u0443\u0441\u0443 \u0437 \u043F\u043E\u0432\u043D\u043E\u044E \u0434\u043E\u0432\u0436\u0438\u043D\u043E\u044E \u043F\u0440\u0435\u0444\u0443\u0437\u0456\u0457 SARS-CoV-2."@uk . "viral"@en . . "GRAd-COV2 \u0648\u064A\u064F\u0639\u0631\u0641 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u062C\u064A \u0622\u0631 \u0623\u064A \u062F\u064A-\u0643\u0648\u06412\u060C \u0647\u0648 \u0644\u0642\u0627\u062D \u0645\u0631\u0634\u062D \u0636\u062F \u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0643\u0648\u0631\u0648\u0646\u0627\u060C \u062A\u0639\u0645\u0644 \u0634\u0631\u0643\u0629 \u00AB\u0631\u064A\u062B\u064A\u0631\u0627\u00BB (\u0628\u0627\u0644\u0625\u064A\u0637\u0627\u0644\u064A\u0629: ReiThera)\u200F \u0627\u0644\u0625\u064A\u0637\u0627\u0644\u064A\u0629 \u0639\u0644\u0649 \u062A\u0637\u0648\u064A\u0631\u0647 \u0648\u0625\u0646\u062A\u0627\u062C\u0647 \u0628\u062A\u0642\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0642\u0644\u0627\u062A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u0629 \u0628\u0627\u0644\u062A\u0639\u0627\u0648\u0646 \u0645\u0639 \u0645\u0639\u0647\u062F \u0644\u0627\u062F\u0632\u0627\u0631\u0648 \u0633\u0628\u0627\u0644\u0627\u0646\u0633\u0627\u0646\u064A \u0627\u0644\u0648\u0637\u0646\u064A \u0644\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0639\u062F\u064A\u0629\u060C \u0648\u0647\u0648 \u0645\u062E\u0635\u0635 \u0644\u0644\u0625\u0639\u0637\u0627\u0621 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u062D\u0642\u0646 \u0627\u0644\u0639\u0636\u0644\u064A."@ar . "GRAd-COV2 is a COVID-19 vaccine candidate developed by ReiThera Srl and Lazzaro Spallanzani National Institute for Infectious Diseases. It is based on a novel replication defective Gorilla Adenovirus and encodes for SARS-COV-2 full length prefusion stabilized Spike protein. More specifically, the vector used is the simian group C adenovirus GRAd32, isolated from a captive gorilla, with a genome deleted of the entire E1 and E3 regions and the native E4 region replaced with the E4 orf6 of human adenovirus 5 (hAd5)."@en . "GRAd-COV2 \u0648\u064A\u064F\u0639\u0631\u0641 \u0623\u064A\u0636\u064B\u0627 \u0628\u0627\u0633\u0645 \u062C\u064A \u0622\u0631 \u0623\u064A \u062F\u064A-\u0643\u0648\u06412\u060C \u0647\u0648 \u0644\u0642\u0627\u062D \u0645\u0631\u0634\u062D \u0636\u062F \u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0643\u0648\u0631\u0648\u0646\u0627\u060C \u062A\u0639\u0645\u0644 \u0634\u0631\u0643\u0629 \u00AB\u0631\u064A\u062B\u064A\u0631\u0627\u00BB (\u0628\u0627\u0644\u0625\u064A\u0637\u0627\u0644\u064A\u0629: ReiThera)\u200F \u0627\u0644\u0625\u064A\u0637\u0627\u0644\u064A\u0629 \u0639\u0644\u0649 \u062A\u0637\u0648\u064A\u0631\u0647 \u0648\u0625\u0646\u062A\u0627\u062C\u0647 \u0628\u062A\u0642\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0642\u0644\u0627\u062A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u0629 \u0628\u0627\u0644\u062A\u0639\u0627\u0648\u0646 \u0645\u0639 \u0645\u0639\u0647\u062F \u0644\u0627\u062F\u0632\u0627\u0631\u0648 \u0633\u0628\u0627\u0644\u0627\u0646\u0633\u0627\u0646\u064A \u0627\u0644\u0648\u0637\u0646\u064A \u0644\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0639\u062F\u064A\u0629\u060C \u0648\u0647\u0648 \u0645\u062E\u0635\u0635 \u0644\u0644\u0625\u0639\u0637\u0627\u0621 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u062D\u0642\u0646 \u0627\u0644\u0639\u0636\u0644\u064A."@ar . "GRAd-Cov-2"@it . . "GRAd-COV2"@ar . . "3774"^^ . . . "GRAd-COV2 \u2014 \u043A\u0430\u043D\u0434\u0438\u0434\u0430\u0442 \u043D\u0430 \u0432\u0430\u043A\u0446\u0438\u043D\u0443 \u043F\u0440\u043E\u0442\u0438 COVID-19, \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0456\u0442\u0430\u043B\u0456\u0439\u0441\u044C\u043A\u0438\u043C\u0438 \u0431\u0456\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0456\u0447\u043D\u043E\u044E \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u00ABReiThera Srl\u00BB \u0442\u0430 \u041D\u0430\u0446\u0456\u043E\u043D\u0430\u043B\u044C\u043D\u0438\u043C \u0456\u043D\u0441\u0442\u0438\u0442\u0443\u0442\u043E\u043C \u0456\u043D\u0444\u0435\u043A\u0446\u0456\u0439\u043D\u0438\u0445 \u0445\u0432\u043E\u0440\u043E\u0431 \u0456\u043C\u0435\u043D\u0456 \u041B\u0430\u0434\u0437\u0430\u0440\u043E \u0421\u043F\u0430\u043B\u043B\u0430\u043D\u0446\u0430\u043D\u0456. \u0412 \u043E\u0441\u043D\u043E\u0432\u0456 \u0446\u0456\u0454\u0457 \u0432\u0430\u043A\u0446\u0438\u043D\u0438 \u043B\u0435\u0436\u0438\u0442\u044C \u043D\u043E\u0432\u0438\u0439 \u0434\u0435\u0444\u0435\u043A\u0442\u043D\u0438\u0439 \u0440\u0435\u043F\u043B\u0456\u043A\u0430\u0446\u0456\u0439\u043D\u0438\u0439\u0443 \u0430\u0434\u0435\u043D\u043E\u0432\u0456\u0440\u0443\u0441 \u0433\u043E\u0440\u0438\u043B\u0438 \u0442\u0430 \u043A\u043E\u0434\u0443\u0454 \u0441\u0442\u0430\u0431\u0456\u043B\u0456\u0437\u043E\u0432\u0430\u043D\u0438\u0439 \u0431\u0456\u043B\u043E\u043A \u0448\u0438\u043F\u043E\u0432\u0438\u0434\u043D\u0438\u0445 \u0432\u0456\u0434\u0440\u043E\u0441\u0442\u043A\u0456\u0432 \u043E\u0431\u043E\u043B\u043E\u043D\u043A\u0438 \u0432\u0456\u0440\u0443\u0441\u0443 \u0437 \u043F\u043E\u0432\u043D\u043E\u044E \u0434\u043E\u0432\u0436\u0438\u043D\u043E\u044E \u043F\u0440\u0435\u0444\u0443\u0437\u0456\u0457 SARS-CoV-2."@uk . . . "GRAd-COV2"@en . . . . . "vaccine"@en . "GRAd-COV2"@uk . . . . . . "Il GRAd-Cov-2 \u00E8 un vaccino contro la COVID-19 sperimentale sviluppato da societ\u00E0 biotecnologica italiana e dall'Istituto nazionale per le malattie infettive italiano \u201CLazzaro Spallanzani\u201D (IRCCS Istituto di Ricovero e Cura a Carattere Scientifico pubblico). I principali finanziatori della ricerca sono la Regione Lazio, il Miur, il socio di maggioranza svizzero Keires, Invitalia e dalla Bill E Melinda Gates Foundation. \u00C8 basato sulla tecnica del vettore virale, in cui un adenovirus del gorilla non replicativo viene indirizzato sul bersaglio della proteina spike del virus."@it . . . . . . . . . "GRAd-COV2 is a COVID-19 vaccine candidate developed by ReiThera Srl and Lazzaro Spallanzani National Institute for Infectious Diseases. It is based on a novel replication defective Gorilla Adenovirus and encodes for SARS-COV-2 full length prefusion stabilized Spike protein. More specifically, the vector used is the simian group C adenovirus GRAd32, isolated from a captive gorilla, with a genome deleted of the entire E1 and E3 regions and the native E4 region replaced with the E4 orf6 of human adenovirus 5 (hAd5)."@en . . . "Il GRAd-Cov-2 \u00E8 un vaccino contro la COVID-19 sperimentale sviluppato da societ\u00E0 biotecnologica italiana e dall'Istituto nazionale per le malattie infettive italiano \u201CLazzaro Spallanzani\u201D (IRCCS Istituto di Ricovero e Cura a Carattere Scientifico pubblico). I principali finanziatori della ricerca sono la Regione Lazio, il Miur, il socio di maggioranza svizzero Keires, Invitalia e dalla Bill E Melinda Gates Foundation. \u00C8 basato sulla tecnica del vettore virale, in cui un adenovirus del gorilla non replicativo viene indirizzato sul bersaglio della proteina spike del virus."@it . . . . . . .